Advinus Therapeutics Ltd. - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Advinus Therapeutics Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Advinus Therapeutics Ltd. - Product Pipeline Review - 2014', provides an overview of the Advinus Therapeutics Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advinus Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Advinus Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Advinus Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Advinus Therapeutics Ltd.'s pipeline products

Reasons to buy

- Evaluate Advinus Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Advinus Therapeutics Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Advinus Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Advinus Therapeutics Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advinus Therapeutics Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Advinus Therapeutics Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Advinus Therapeutics Ltd. Snapshot 6
Advinus Therapeutics Ltd. Overview 6
Key Information 6
Key Facts 6
Advinus Therapeutics Ltd. - Research and Development Overview 7
Key Therapeutic Areas 7
Advinus Therapeutics Ltd. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Advinus Therapeutics Ltd. - Pipeline Products Glance 14
Advinus Therapeutics Ltd. - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Advinus Therapeutics Ltd. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Advinus Therapeutics Ltd. - Drug Profiles 17
GKM-001 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecule For Type 2 Diabetes 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Adenosine A-2A Antagonist for Parkinson Disease 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Compound-26g 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
PNQ-103 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PNQ-201 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Inhibit FAAH for Pain 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Inhibit Janus Kinase 3/1 for Rheumatoid Arthritis 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
GPR40 and GPR120 Dual Agonist for Type 2 Diabetes 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Neglected Disease Program 2 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Nitroimidazole Backup Compound 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
RAR-Related Orphan Receptor Gamma Antagonist for Psoriasis 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule to Inhibit Bruton's Tyrosine Kinase for Auto Immune Diseases 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecule to Inhibit Selective Janus Kinase 1 for Rheumatoid Arthritis 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules to Inhibit GPR40 for Obesity 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecules to Inhibit GPR91 for Retinal Angiogenesis and Liver Fibrosis 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Advinus Therapeutics Ltd. - Pipeline Analysis 34
Advinus Therapeutics Ltd. - Pipeline Products by Target 34
Advinus Therapeutics Ltd. - Pipeline Products by Route of Administration 36
Advinus Therapeutics Ltd. - Pipeline Products by Molecule Type 37
Advinus Therapeutics Ltd. - Pipeline Products by Mechanism of Action 38
Advinus Therapeutics Ltd. - Recent Pipeline Updates 40
Advinus Therapeutics Ltd. - Dormant Projects 41
Advinus Therapeutics Ltd. - Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
Advinus Therapeutics Ltd., Key Information 6
Advinus Therapeutics Ltd., Key Facts 6
Advinus Therapeutics Ltd. - Pipeline by Indication, 2014 9
Advinus Therapeutics Ltd. - Pipeline by Stage of Development, 2014 10
Advinus Therapeutics Ltd. - Monotherapy Products in Pipeline, 2014 11
Advinus Therapeutics Ltd. - Partnered Products in Pipeline, 2014 12
Advinus Therapeutics Ltd. - Partnered Products/ Combination Treatment Modalities, 2014 13
Advinus Therapeutics Ltd. - Phase II, 2014 14
Advinus Therapeutics Ltd. - Preclinical, 2014 15
Advinus Therapeutics Ltd. - Discovery, 2014 16
Advinus Therapeutics Ltd. - Pipeline by Target, 2014 35
Advinus Therapeutics Ltd. - Pipeline by Route of Administration, 2014 36
Advinus Therapeutics Ltd. - Pipeline by Molecule Type, 2014 37
Advinus Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2014 39
Advinus Therapeutics Ltd. - Recent Pipeline Updates, 2014 40
Advinus Therapeutics Ltd. - Dormant Developmental Projects,2014 41
Advinus Therapeutics Ltd., Other Locations 42